Shipment courier

Taiwan receives shipment of 600,000 Pfizer-BioNTech vaccines

Taipei, Aug. 29 (CNA) Taiwan took delivery on Monday of a shipment of more than 600,000 doses of the Pfizer-BioNTech COVID-19 vaccine, which will be used as priority boosters for children aged 12 to 17, according to the Central Epidemic Command Center (CECC).

The 602,550 doses of Pfizer-BioNTech arrived at Taoyuan International Airport on Monday morning and were transferred to a cold chain logistics center for inspection, CECC Director Victor Wang (王必勝) said. , during a press briefing.

Wang said the new batch of vaccines expires on March 21, 2023, and will be used primarily as a booster for children aged 12 to 17, many of whom received first and second vaccines from the same brand in the second half of 2021.

Earlier this year, Taiwan signed agreements to purchase 3.3 million Pfizer-BioNTech COVID-19 vaccines for children aged 5 to 11, 1.9 million doses for young children aged 6 months to 4 years and 1.8 million doses for adults, with an option to purchase. 4 million additional adult vaccines if needed.

To date, Taiwan has received 2.20 million doses of vaccines for children aged 5 to 11 years, 1.27 million doses for children aged 6 months to 4 years and 2.46 million doses for adults, according to the CECC.

As of August 22, 92.4% of eligible people in Taiwan had received a first COVID-19 vaccine, while 86.4% had received a second vaccine and 72.0% had received a first booster.

Among children, 94.7% of those aged 12 to 17 had received at least one vaccine injection, compared with 78.1% of those aged 5 to 11 and 19.2% of those aged 6 months to 4 years, according to statistics.

(By Chen Chieh-ling, Chang Ming-hsuan and Matthew Mazzetta)

End article/HY

> Chinese version